Search

DISTRIBUTION OF IMMUNE POPULATIONS IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA

Skin Cancers

Zipei Feng¹, Daniel Bethmann, MD², Matthias Kappler, MD³, Carmen Ballesteros-Merino, PhD⁴, Alexander Eckert, MD³, R. Bryan Bell, MD, DDS⁵, Allen Cheng, MD, DDS⁵, Tuan Bui, MD, DMD⁵, Rom Leidner, MD⁴, Carlo Bifulco, MD⁴, Claudia Wickenhauser, MD², Barbara Seliger, PhD⁶, Bernard Fox, PhD⁴

¹Oregon Health & Science University, Department of Cell, Development & Cancer Biology, ²Martin Luther University Halle-Wittenberg, Institute of Pathology, Halle, Germany, ³Martin Luther University Halle-Wittenberg, Department of Oral and Maxillofacial Plastic Surgery, ⁴Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, ⁵Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center, Portland, OR, ⁶Martin Luther University Halle-Wittenberg, Institute of Medical Immunology

RISK AND SURVIVAL OF PATIENTS WITH HEAD AND NECK CUTANEOUS MELANOMA: NATIONAL PERSPECTIVE

Skin Cancers

Zaid Al-Qurayshi¹, Khuzema Mohsin, MD¹, Sudesh Srivastav², Emad Kandil¹

¹Tulane University School of Medicine, ²Tulane University School of Public Health and Tropical Medicine

CUTANEOUS HEAD AND NECK ANGIOSARCOMA: POORER LOCAL CONTROL AND SURVIVAL FOR SCALP THAN FACE

Skin Cancers

Jonathan M Bernstein, MD, FRCS¹, Brian O' Sullivan, MD, FRCPC², Jonathan C Irish, MD, MSc, FRCSC¹

¹Department of Otolaryngology - Head & Neck Surgery, Princess Margaret Cancer Centre, University of Toronto, ²Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto

ONCOLOGIC OUTCOMES AND PROGNOSTIC FACTORS OF THE HEAD AND NECK ANGIOSARCOMA TREATED IN A SINGLE INSTITUTION

Skin Cancers

Hung-Wei Yang, Hui-Fu Huang, Hao-Chih Tai, Chen-Hsiang Kuan

National Taiwan University Hospital

PROGNOSTIC FACTORS IN DETERMINING THE OUTCOME OF HEAD AND NECK CUTANEOUS MELANOMA

Skin Cancers

Kristyn Buchko, K.Alok Pathak

CancerCare Manitoba

TREATMENT AND OUTCOME OF ADVANCED EXTERNAL AUDITORY CANAL AND MIDDLE EAR MALIGNANT TUMORS

Skin Cancers

Giovanni Cristalli, MD, Giuseppe Mercante, MD, Valentina Manciocco, PhD, Giuseppe Spriano, MD

Regina Elena National Cancer Institute

TOTAL RADIATION DOSE DELIVERED IMPACTS SURVIVAL IN HEAD AND NECK MERKEL CELL CARCINOMA PATIENTS RECEIVING SURGERY WITH ADJUVANT RADIATION.

Skin Cancers

Minh Tam Truong, MD¹, Muhammad M Qureshi, MBBS², Diana Kirke, MD¹, Debjani Sahni, MD¹, Scharukh Jalisi, MD¹, Waleed Ezzat, MD¹

¹Boston Medical Center, ²Boston University School of Medicine

DESMOPLASTIC MELANOMA OF THE HEAD AND NECK: IS THERE A ROLE FOR SENTINEL LYMPH NODE BIOPSY?

Skin Cancers

Dylan F Roden, MD, MPH¹, Anna C Pavlick, DO², Mark D DeLacure, MD¹

¹Department of Otolaryngology - Head & Neck Surgery, New York University, ²Department of Medical Oncology, New York University

NEOADJUVANT BRAF/MEK CO-INHIBITION: A PARADIGM SHIFT IN THE TREATMENT OF MARGINALLY RESECTABLE LOCOREGIONALLY ADVANCED HEAD & NECK MELANOMA

Skin Cancers

Danish A Nagda, MD, Lynn A Cornelius, MD, Gerry P Linette, MD, PhD, Rebecca D Chernock, MD, Brian Nussenbaum, MD

Washington University School of Medicine in St Louis

THE CHANGING FACE OF INPATIENT CUTANEOUS CANCER CARE OF THE TRANSPLANT PATIENT

Skin Cancers

Thomas K Chung¹, Cecelia Schmalbach²

¹University of Alabama at Birmingham, ²Indiana University